Evidence map›Paper›PMID 36503487›Full record

ReviewJournal of translational medicine2022

The role of the oral microbiome in smoking-related cardiovascular risk: a review of the literature exploring mechanisms and pathways.

Katherine A Maki, Sukirth M Ganesan, Brianna Meeks, Nicole Farmer, Narjis Kazmi, Jennifer J Barb, Paule V Joseph, Gwenyth R Wallen

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Journal of translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06684483 (Quantifying Associations of Stress and Inflammation-Associated Oral Biomarkers With Oral Health, Oral Health Behaviors, Systemic Biomarkers and Clinical Phenotype in Individuals With Alcohol Use Disorder), which is not on this map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06684483 recruitingnot on this mapstarted 2025, after this paper: background citation

Quantifying Associations of Stress and Inflammation-Associated Oral Biomarkers With Oral Health, Oral Health Behaviors, Systemic Biomarkers and Clinical Phenotype in Individuals With Alcohol Use Disorder (AUD)

TypeobservationalSponsorNational Institutes of Health Clinical Center (CC)Ran2025 to 2026Enrolled72ConditionsAlcohol Use Disorder, Alcohol Dependence
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Elimination of oral foci of infection might lead to clinical improvement of Graves' orbitopathy.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Article
  12. Review
  13. Article
  14. Observational
  15. Article
  16. Article
  17. The oral microbiome and all-cause mortality in the US population.medRxiv : the preprint server for health sciences · 2024
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Katherine A MakiTranslational Biobehavioral and Health Disparities Branch, National Institutes of Health, Clinical Center, 10 Center Drive, Building 10, Bethesda, MD, 20814, USA.ORCID http://orcid.org/0000-0003-4578-960X
Sukirth M GanesanDepartment of Periodontics, The University of Iowa College of Dentistry and Dental Clinics, 801 Newton Rd., Iowa City, IA, 52242, USA.
Brianna MeeksUniversity of Maryland, School of Social Work, Baltimore, MD, USA.
Nicole FarmerTranslational Biobehavioral and Health Disparities Branch, National Institutes of Health, Clinical Center, 10 Center Drive, Building 10, Bethesda, MD, 20814, USA.
Narjis KazmiTranslational Biobehavioral and Health Disparities Branch, National Institutes of Health, Clinical Center, 10 Center Drive, Building 10, Bethesda, MD, 20814, USA.
Jennifer J BarbTranslational Biobehavioral and Health Disparities Branch, National Institutes of Health, Clinical Center, 10 Center Drive, Building 10, Bethesda, MD, 20814, USA.
Paule V JosephNational Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.
Gwenyth R WallenTranslational Biobehavioral and Health Disparities Branch, National Institutes of Health, Clinical Center, 10 Center Drive, Building 10, Bethesda, MD, 20814, USA. Gwallen@cc.nih.gov.ORCID http://orcid.org/0000-0001-7134-1636
National Institutes of Health Clinical Center · USNational Institute on Minority Health and Health Disparities · USNational Institutes of Health · USUniversity of Iowa · USUniversity of Maryland, Baltimore · US

Funding

National Institutes of Health, Clinical Center intramural research fundsNIAAA NIH HHS intramural research funds
6 · The paper itself

Abstract

Cardiovascular disease is a leading cause of morbidity and mortality. Oral health is associated with smoking and cardiovascular outcomes, but there are gaps in knowledge of many mechanisms connecting smoking to cardiovascular risk. Therefore, the aim of this review is to synthesize literature on smoking and the oral microbiome, and smoking and cardiovascular risk/disease, respectively. A secondary aim is to identify common associations between the oral microbiome and cardiovascular risk/disease to smoking, respectively, to identify potential shared oral microbiome-associated mechanisms. We identified several oral bacteria across varying studies that were associated with smoking. Atopobium, Gemella, Megasphaera, Mycoplasma, Porphyromonas, Prevotella, Rothia, Treponema, and Veillonella were increased, while Bergeyella, Haemophilus, Lautropia, and Neisseria were decreased in the oral microbiome of smokers versus non-smokers. Several bacteria that were increased in the oral microbiome of smokers were also positively associated with cardiovascular outcomes including Porphyromonas, Prevotella, Treponema, and Veillonella. We review possible mechanisms that may link the oral microbiome to smoking and cardiovascular risk including inflammation, modulation of amino acids and lipids, and nitric oxide modulation. Our hope is this review will inform future research targeting the microbiome and smoking-related cardiovascular disease so possible microbial targets for cardiovascular risk reduction can be identified.

Indexed as

Cardiovascular DiseasesBacteriaHeart Disease Risk FactorsHumansRisk FactorsRNA, Ribosomal, 16SSmokingRNA, Ribosomal, 16SCardiovascular diseaseCardiovascular riskGeneticsMicrobiotaOral healthOral microbiomeSmoking

Identifiers

PMID36503487
PMCPMC9743777
OpenAlexW4311125552

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.